Dr. Sunny Malhotra Sareen
Dr. Sunny Malhotra Sareen
Researcher, Vall d´ hebron
Dirección de correo verificada de vhir.org
Título
Citado por
Citado por
Año
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis
S Malhotra, J Río, E Urcelay, R Nurtdinov, MF Bustamante, O Fernández, ...
Brain 138 (3), 644-652, 2015
822015
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
A Goris, I Pauwels, MW Gustavsen, B Van Son, K Hilven, SD Bos, ...
Brain 138 (3), 632-643, 2015
582015
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis
International Multiple Sclerosis Genetics Consortium
Brain 136 (6), 1778-1782, 2013
512013
Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis
S Malhotra, MF Bustamante, F Pérez-Miralles, J Rio, MCR de Villa, ...
PLoS One 6 (8), e23634, 2011
472011
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon‐β treatment
S Malhotra, C Morcillo‐Suarez, R Nurtdinov, J Rio, E Sarro, M Moreno, ...
European journal of neurology 20 (10), 1390-1397, 2013
322013
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis
F Matesanz, V Potenciano, M Fedetz, P Ramos-Mozo, MM Abad-Grau, ...
Human molecular genetics 24 (19), 5619-5627, 2015
312015
Genome-wide significant association with seven novel multiple sclerosis risk loci
CM Lill, F Luessi, A Alcina, EA Sokolova, N Ugidos, B de la Hera, ...
Journal of medical genetics 52 (12), 848-855, 2015
302015
Ancient and recent selective pressures shaped genetic diversity at AIM2-like nucleic acid sensors
R Cagliani, D Forni, M Biasin, M Comabella, FR Guerini, S Riva, ...
Genome biology and evolution 6 (4), 830-845, 2014
282014
TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis
M Comabella, AB Caminero, S Malhotra, L Agulló, O Fernández, ...
Neurology 80 (22), 2010-2016, 2013
262013
Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β
MF Bustamante, C Morcillo-Suárez, S Malhotra, J Rio, L Leyva, ...
Neurology-Neuroimmunology Neuroinflammation 2 (5), 2015
242015
IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis
S Malhotra, C Morcillo-Suárez, D Brassat, R Goertsches, J Lechner-Scott, ...
Journal of neuroimmunology 239 (1-2), 101-104, 2011
242011
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
S Malhotra, C Costa, H Eixarch, CW Keller, L Amman, ...
Brain 143 (5), 1414-1430, 2020
222020
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
S Malhotra, N Fissolo, M Tintoré, AC Wing, J Castilló, A Vidal-Jordana, ...
Journal of neuroinflammation 12 (1), 1-5, 2015
212015
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study
S Mahurkar, M Moldovan, V Suppiah, M Sorosina, F Clarelli, G Liberatore, ...
The pharmacogenomics journal 17 (4), 312-318, 2017
202017
NR1H3 p. Arg415Gln is not associated to multiple sclerosis risk
J Antel, M Ban, S Baranzini, L Barcellos, N Barizzone, A Beecham, ...
Neuron 92 (2), 333-335, 2016
202016
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles
B De La Hera, E Urcelay, D Brassat, A Chan, A Vidal-Jordana, A Salmen, ...
Neurology-Neuroimmunology Neuroinflammation 1 (4), 2014
192014
SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis
S Malhotra, J Castilló, MF Bustamante, A Vidal-Jordana, Z Castro, ...
Multiple Sclerosis Journal 19 (5), 524-531, 2013
162013
Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course
E Gil-Varea, E Urcelay, C Vilariño-Güell, C Costa, L Midaglia, F Matesanz, ...
Journal of neuroinflammation 15 (1), 1-10, 2018
132018
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis
A Haghikia, S Faissner, D Pappas, B Pula, DA Akkad, L Arning, ...
Multiple Sclerosis Journal 21 (10), 1262-1270, 2015
112015
Chitinase 3-like 1 is associated with the response to interferon-beta treatment in multiple sclerosis
C Matute-Blanch, J Río, LM Villar, L Midaglia, S Malhotra, ...
Journal of neuroimmunology 303, 62-65, 2017
102017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20